CAFFEINE FOR THE TREATMENT OF MYOTONIC DYSTROPHY TYPE 1 AND TYPE 2

The present invention relates to caffeine for use in the treatment of myotonic dystrophy type 1 and type 2. The present invention also relates to compositions comprising caffeine for use in the treatment of myotonic dystrophy type 1 and type 2.

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	ARTERO ALLEPUZ, Ruben, ESTRADA TEJEDOR, Roger, PASCUAL GILABERT, Marta, TEIXIDÓ CLOSA, Jordi, BORRELL BILBAO, José Ignacio, LÓPEZ GONZÁLEZ, Alejandro, CASTELLS BOLIART, Josep, LLAMUSI TROÍSI, Beatriz, BARGIELA SCHÖNBRUNN, Ariadna, KONIECZNY, Piotr
Format:	Patent
Sprache:	eng ; fre ; ger
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention relates to caffeine for use in the treatment of myotonic dystrophy type 1 and type 2. The present invention also relates to compositions comprising caffeine for use in the treatment of myotonic dystrophy type 1 and type 2.